Omega Funds
Investor profile
Venture capital
Omega Funds has backed 11 European tech companies across 13 funding rounds between 2020 and 2026, joining rounds totalling €588M. Most active in Healthtech and Edtech. Data as of Nov 2026.
Also recorded as: Omega · Omega Venture Partners · Omega Ventures
Deals
13
distinct rounds
Companies
11
backed
Active span
2020–2026
7 yrs
Total round €
€588M
sum of rounds joined
Deals by year
distinct rounds / yearOmega Funds — deals by year — interactive chart.
Data table
| Omega Funds — deals by year | |
|---|---|
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Top sectors
by dealsOmega Funds — top sectors — interactive chart.
Data table
| Omega Funds — top sectors | |
|---|---|
| Healthtech | 10 |
| Edtech | 1 |
| Legaltech | 1 |
| Software | 1 |
Stages
by dealsOmega Funds — stages — interactive chart.
Data table
| Omega Funds — stages | |
|---|---|
| Series A | 5 |
| Other | 2 |
| Series B | 2 |
| Series C | 2 |
| Seed | 1 |
| Series D+ | 1 |
Countries
by dealsOmega Funds — countries — interactive chart.
Data table
| Omega Funds — countries | |
|---|---|
| UK | 5 |
| Iceland | 2 |
| Switzerland | 2 |
| Belgium | 1 |
| Finland | 1 |
| Italy | 1 |
| Spain | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Andera Partners2
- Avidity Partners2
- Brandon Capital2
- Invus2
- M Ventures2
- Novartis Venture Fund2
- Pfizer Ventures2
- Piper Heartland Healthcare Capital2
- Schroders Capital2
- Sofinnova Partners2
- SV Health Investors2
- Abingworth LLP1
- Asabys Partners1
- Bain Capital Life Sciences1
- British Business Bank1
- CaaS Capital Management1
- CDTI1
- Co-Investment Fund (FOCO)1
- Criteria Bio Ventures1
- Deep Track Capital1
- EQT Life Sciences1
- European Investment Bank (EIB)1
- Frumtak Ventures1
- FundPlus1
- GIMV1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Artios | UK | 2 | €229M |
| NRG Therapeutics | UK | 2 | €76M |
| EyeBiotech | UK | 1 | €61M |
| SoniVie | Italy | 1 | €56M |
| Anjarium Biosciences | Switzerland | 1 | €51M |
| Anaconda Biomed | Spain | 1 | €49M |
| eTheRNA | Belgium | 1 | €39M |
| Chord Therapeutics | Switzerland | 1 | €14M |
| Treble Technologies | Iceland | 1 | €11M |
| Aavalynx | Finland | 1 | €1.8M |
| Evolytes | Iceland | 1 | €1.3M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Artios | Series C | €130M | 2021-07 |
| Artios | Series D+ | €99M | 2025-11 |
| EyeBiotech | Series A | €61M | 2023-11 |
| NRG Therapeutics | Series B | €58M | 2025-09 |
| SoniVie | Series C | €56M | 2023-01 |
| Anjarium Biosciences | Series A | €51M | 2021-09 |
| eTheRNA | Series B | €39M | 2022-08 |
| NRG Therapeutics | Series A | €18M | 2022-11 |
| Chord Therapeutics | Series A | €14M | 2020-10 |
| Treble Technologies | Series A | €11M | 2024-09 |